Replies to post #212680 on Biotech Values

[DewDiligence]

DVAX—FDA advisory panel backs Heplisav in 11-1-3 vote:

VOTE: Do the available data support the safety of Heplisav-B when administered to adults?
11-Yes
1-No
3-Abstain$DVAX

— SAC Tracker (@FDAadcomm) July 28, 2017